DPUK is delighted to announce that Prof Vanessa Raymont has taken over as Director. She replaces Prof John Gallacher who is stepping down after more than 10 years in the role. She will be shaping DPUK's future at an exciting time in dementia research.

Our #READ-OUT research study is part of the #BloodBiomarkerChallenge. With funding from the People's Postcode Lottery we can bring a simple blood test to the NHS, transforming the scale of dementia diagnosis in the NHS. zurl.co/bkPIW Thanks to @alzheimersresearchuk.org @alzheimerssoc.bsky.social

DPUK's Imaging Network has completed a harmonisation and a test/retest study across our Imaging Network on PET and MR scans. Read more Blog zurl.co/wkjmG Pawel Markiewicz's paper in European Journal of Nuclear Medicine and Molecular Imaging zurl.co/ACCTj

The FAST Brain Health Study has 11 new sites zurl.co/M378G , making it easier for people to be part of research into brain health, ageing, and dementia risk. with 5 new sites in Scotland, FAST is reaching a far wider part of the UK population. Read more zurl.co/zyiDM

What great people! Brilliant to see the energy, ideas and expertise presented at our synaptic health & neurouimmunology data event today @cam.ac.uk It is driving understanding and accelerating discoveries and making a real-world impact in dementia research.

Help us to understand public and patient views about new blood tests for dementia and other memory problems. Complete our online survey and tell us your attitude to taking such a test as well as the factors influencing a decision. Take the test: zurl.co/3vSxJ

READ-OUT

zurl.co

Help us to understand public and patient views about new blood tests for dementia and other memory problems. Complete our online survey and tell us your attitude to taking such a test as well as the factors influencing a decision. Take the test: zurl.co/3vSxJ

READ-OUT

zurl.co

DPUK is delighted to be part of the Blood Biomarker Challenge, funded by the People's Postcode Lottery UK. Together we are helping to improve the lives of people at risk of dementia. Watch this video. Like and share. zurl.co/HOWyJ

ONE DAY. BIG IDEAS to drive understanding, spark discovery & create impact. * Latest datasets & findings * Discover high quality resources * New opportunities for analysis/reuse. * Connect. with ideas & collaborations. Move the field forward. Interested? dpuk@psych.ox.ac.uk

You can make research and trials easier with our Trials Delivery Framework. Find out more zurl.co/uJ321

Our READ-OUT study is helping to shape how the NHS can use blood biomarkers to increase the number of people getting an accurate dementia diagnosis. It's part of the Blood Biomarker Challenge, a multi-million pound initiative led by Alzheimer’s Society, Alzheimer’s Research UK.

DPUK's data portal has multimodal data available to researchers: 👩‍👩‍👧‍👦 >107 datasets with epidemiologic and clinical data (n>3.5m), 🧠>300,000 neuroimaging scans across 20 cohorts, and ⛓️genomic data for >140,000 participants from 16 cohorts. zurl.co/HztoH

DPUK's Trials Delivery Framework can reduce screen failures causing trial delays, rising costs and frustration for patients. Find out about our Feasibility Tool, tailored to identify the most relevant and appropriate people for your research. zurl.co/TQhgt

Great Minds recruits highly characterised volunteers willing to participate in experimental medicine and clinical trials. It's a register that continues to grow with around 13,500 people available as candidates for research. #trialsdelivery #dementia zurl.co/5ddpT

With 107 multimodal datasets and access to records of 3.5m people, all the analytical tools you need plus your own working space, there are plenty of reasons to make use of our Data Portal. Best of all, it is FREE to use. Find out more: zurl.co/yzXsk

DPUK's network of 80+ Trials Delivery sites across the UK is available for 📊Collecting patient data 💉Plasma biomarkers & digital cognitive assessments 📌Study & Trial centres 👩‍👩‍👧‍👦 Recruiting to registers, studies & trials. Find out more: zurl.co/YC8jP

Great to have such good converations about DPUK at #ADPD2026. As Prof Sarah Bauermeister commented: "The high level of interest in our Data Portal and Trials Delivery Network showed how essential they are for human-based and translational research." zurl.co/iMiXv

Please share with your colleagues with research interests in adolescence or teenage mental health and wellbeing. This is a fascinating conference to attend. #teens #adolescent #wellbeing #schools #education mentalhealth #depression #anxiety #learning zurl.co/ucFwb

BrainWaves Living Well 2026 - BrainWaves

BrainWaves Living Well 2026 is a unique scientific and educational conference that brings together researchers, educators, and partners.

zurl.co

We’re excited to be at Booth 04 at #ADPD2026 with the Alzheimer's Disease Data Initiative showcasing interopability & how @dementiasplatform.bsky.social (Dementias Platform UK) helps accelerate #ADPD research. It is the place to find out about our free-to-use DPUK Data Portal. zurl.co/42Cs7

We're looking forward to seeing you at #ADPD2026 in Copenhagen this week. Find us at the @AlzData (ADDI) stand. Come and find out about our free-to-access Data Portal and UK Trials Delivery network. #dementia #brain #cognition #neurodegeneration

It's great to have Tees, Esk and Wear Valleys NHS Foundation Trust starting to recruit participants in our #READ-OUT study - helping to bring effective early diagnosis of dementia to more people in the NHS 🔗READ MORE - zurl.co/QJevL

Trial using blood tests to diagnose dementia comes to the North East

A groundbreaking trial exploring the potential of blood tests to diagnose dementia is now underway in Tees, Esk and Wear Valleys NHS Foundation Trust.

hellorayo.co.uk

Have you used the Data Portal at Dementias Platform UK yet? It's FREE-TO ACCESS all 107 datasets. Take a look yourself and see how it can help you. #translationalmedicine #healthdata #dementia #cognition #neuroimaging zurl.co/NVOPb

We're busy meeting lots of researchers at #FORACURE ARUK Research conference in Manchester. Grab a coffee and come for a chat to find out how you can use our Data Portal and Trials Delivery Network for FREE.

There is plenty to talk about at #ARUK2026. Please call round to say "hello".

Blood Biomarkers can widen access to #dementia diagnosis in less well-resourced settings where gold-standard PET and lumber puncture tests are hard to access. They are scalable and could be used in low- and middle-income countries #LMICs to extend accurate diagnosis. zurl.co/dTu4m

DPUK’s focus: building “complex knowledge” — integrating imaging, genomics, biomarkers, trials and AI etc., within shared research architectures. Connecting these disciplines is a force multiplier for #dementia discovery. #DementiaResearch #TranslationalScience zurl.co/oKkaN

Targeting toxic protein chains could slow neurodegenerative disease flip.it/zefWMZ

Targeting toxic protein chains could slow neurodegenerative disease

New research reveals that repetitive strings of the amino acid serine can kill brain cells and accelerate the formation of toxic tau tangles associated with Alzheimer’s disease.

flip.it

DPUK is advancing cross-platform data federation with international partners, enabling secure analysis without data transfer. A practical solution to global collaboration while preserving governance standards. #DataFederation #OpenScience zurl.co/mbRTe

DPUK's Trials Delivery Framework is the largest dementia-focused network in the UK, with participant registers and a UK-wide clinical network. Read more about the expanding reach and growing use of our resources in our latest Annual Report. Download your copy now: zurl.co/TYthy

"Our progress has relied on developing a high trust, pre-competitive environment in which collaboration thrives." (Prof John Gallacher) Read more about our science, resources & activities. DPUK Annual Report 2025: Embracing Complexity. zurl.co/uMVSw #dementia #MCI #neurodegeneration